Please use this identifier to cite or link to this item: https://doi.org/10.46883/2023.25920992
DC FieldValue
dc.titleCirculating Tumor DNA as a Predictive Biomarker for Clinical Outcomes With Margetuximab and Pembrolizumab in Pretreated HER2-Positive Gastric/ Gastroesophageal Adenocarcinoma
dc.contributor.authorDaniel V. T. Catenacci
dc.contributor.authorYoon-Koo Kang
dc.contributor.authorHope E. Uronis
dc.contributor.authorKeun-Wook Lee
dc.contributor.authorMatthew C. H. Ng
dc.contributor.authorPeter C. Enzinger
dc.contributor.authorSe Hoon Park
dc.contributor.authorPhilip J. Gold
dc.contributor.authorJill Lacy
dc.contributor.authorHoward S. Hochster
dc.contributor.authorSang Cheul Oh
dc.contributor.authorYeul Hong Kim
dc.contributor.authorKristen A. Marrone
dc.contributor.authorRonan J. Kelly
dc.contributor.authorRosalyn A. Juergens
dc.contributor.authorJong Gwang Kim
dc.contributor.authorThierry Alcindor
dc.contributor.authorSun Jin Sym
dc.contributor.authorEun-Kee Song
dc.contributor.authorCheng Ean Chee
dc.contributor.authorYee Chao
dc.contributor.authorSunnie Kim
dc.contributor.authorDo-Youn Oh
dc.contributor.authorJennifer Yen
dc.contributor.authorJustin I. Odegaard
dc.contributor.authorErrin Lagow
dc.contributor.authorDaner Li
dc.contributor.authorJichao Sun
dc.contributor.authorPatrick Kaminker
dc.contributor.authorPaul A. Moore
dc.contributor.authorMinori Koshiji Rosales
dc.contributor.authorHaeseong Park
dc.date.accessioned2023-05-10T00:01:44Z
dc.date.available2023-05-10T00:01:44Z
dc.date.issued2023-04-12
dc.identifier.citationDaniel V. T. Catenacci, Yoon-Koo Kang, Hope E. Uronis, Keun-Wook Lee, Matthew C. H. Ng, Peter C. Enzinger, Se Hoon Park, Philip J. Gold, Jill Lacy, Howard S. Hochster, Sang Cheul Oh, Yeul Hong Kim, Kristen A. Marrone, Ronan J. Kelly, Rosalyn A. Juergens, Jong Gwang Kim, Thierry Alcindor, Sun Jin Sym, Eun-Kee Song, Cheng Ean Chee, Yee Chao, Sunnie Kim, Do-Youn Oh, Jennifer Yen, Justin I. Odegaard, Errin Lagow, Daner Li, Jichao Sun, Patrick Kaminker, Paul A. Moore, Minori Koshiji Rosales, Haeseong Park (2023-04-12). Circulating Tumor DNA as a Predictive Biomarker for Clinical Outcomes With Margetuximab and Pembrolizumab in Pretreated HER2-Positive Gastric/ Gastroesophageal Adenocarcinoma. ONCOLOGY (3704) : 176-183. ScholarBank@NUS Repository. https://doi.org/10.46883/2023.25920992
dc.identifier.issn0890-9091
dc.identifier.urihttps://scholarbank.nus.edu.sg/handle/10635/239260
dc.publisherMJH Life Sciences
dc.sourceElements
dc.typeArticle
dc.date.updated2023-05-09T08:07:01Z
dc.contributor.departmentMEDICINE
dc.contributor.departmentDUKE-NUS MEDICAL SCHOOL
dc.description.doi10.46883/2023.25920992
dc.description.sourcetitleONCOLOGY
dc.description.issue3704
dc.description.page176-183
dc.published.statePublished
Appears in Collections:Staff Publications
Elements

Show simple item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
Catenacci_Oncology 2023+Suppl.pdf2.31 MBAdobe PDF

CLOSED

None

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.